Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR.
about
Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Validation of a molecular diag ...... a novel 9 bp deletion in CALR.
@en
Validation of a molecular diag ...... a novel 9 bp deletion in CALR.
@nl
type
label
Validation of a molecular diag ...... a novel 9 bp deletion in CALR.
@en
Validation of a molecular diag ...... a novel 9 bp deletion in CALR.
@nl
prefLabel
Validation of a molecular diag ...... a novel 9 bp deletion in CALR.
@en
Validation of a molecular diag ...... a novel 9 bp deletion in CALR.
@nl
P2093
P2860
P356
P1476
Validation of a molecular diag ...... a novel 9 bp deletion in CALR.
@en
P2093
G Murugesan
J Guenther-Johnson
P2860
P304
P356
10.1111/IJLH.12484
P577
2016-03-28T00:00:00Z